Paola Chiani Selected Research

Paola Chiani Research Topics

4	Candidiasis (Moniliasis) 02/2010 - 01/2002
3	Mycoses (Diseases, Fungus) 09/2011 - 11/2007
2	Infections 02/2010 - 09/2005
1	Diarrhea 08/2022
1	Hemolytic-Uremic Syndrome 10/2018
1	Septic Shock (Toxic Shock Syndrome) 01/2017
1	Systemic candidiasis 01/2009
1	Hypersensitivity (Allergy) 09/2005
1	Invasive Candidiasis 10/2002
1	Oral Candidiasis (Thrush) 01/2002

4	AntibodiesIBA 01/2017 - 10/2002
3	beta-GlucansIBA 03/2010 - 11/2007
3	VaccinesIBA 03/2010 - 10/2002
2	Conjugate VaccinesIBA 03/2010 - 02/2010
2	Immunoglobulin G (IgG)IBA 02/2010 - 01/2009
1	Ampicillin (Omnipen)FDA LinkGeneric 08/2022
1	Tetracycline (Achromycin)FDA LinkGeneric 08/2022
1	Shiga Toxin (Shigella Toxin)IBA 10/2018
1	GlucansIBA 09/2011
1	laminaranIBA 03/2010
1	CRM197 (non-toxic variant of diphtheria toxin)IBA 03/2010
1	EpitopesIBA 03/2010
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 03/2010
1	OligosaccharidesIBA 03/2010
1	MF59 oil emulsionIBA 02/2010
1	AntigensIBA 09/2005
1	CytokinesIBA 09/2005
1	lipoarabinomannan (LAM)IBA 09/2005
1	HIV Protease InhibitorsIBA 01/2002
1	Reverse Transcriptase InhibitorsIBA 01/2002
1	Aspartic Acid ProteasesIBA 01/2002
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2002

1	Immunotherapy 09/2011
1	Therapeutics 01/2002
1	Highly Active Antiretroviral Therapy (HAART) 01/2002